EcoR1 Capital, LLC Quant / Systematic

Location: San Francisco, CA

CIK: 0001587114 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $326M (100.0% shares, 0.0% debt)

Holdings (31)

IRWD IRONWOOD PHARMACEUTICALS INC 13.7%
Value $44.63M Shares 2,810,315 Est. Cost $9.33 Unrealized +25.3%
GLPG GALAPAGOS NV 9.9%
Value $32.37M Shares 500,576 Est. Cost $56.91 Unrealized
BRISTOL MYERS SQUIBB CO 8.3%
Value $26.96M Shares 500,000 Est. Cost Unrealized
ASSEMBLY BIOSCIENCES INC 6.5%
Value $21.22M Shares 2,943,164 Est. Cost $8.38 Unrealized
DERMIRA INC 5.4%
Value $17.65M Shares 522,000 Est. Cost $31.44 Unrealized
ARDX ARDELYX INC 5.2%
Value $16.95M Shares 1,310,023 Est. Cost $10.48 Unrealized 0.0%
KURA KURA ONCOLOGY INC 5.0%
Value $16.32M Shares 2,611,906 Est. Cost $10.12 Unrealized -49.9%
FIVE PRIME THERAPEUTICS INC 4.6%
Value $15.04M Shares 286,612 Est. Cost $52.49 Unrealized
FIBROGEN INC 4.4%
Value $14.2M Shares 686,184 Est. Cost $24.72 Unrealized
GILEAD SCIENCES INC 3.6%
Value $11.87M Shares 150,000 Est. Cost Unrealized
ALLERGAN PLC 3.5%
Value $11.52M Shares 50,000 Est. Cost Unrealized
AGIO AGIOS PHARMACEUTICALS INC 3.2%
Value $10.56M Shares 200,000 Est. Cost $43.55 Unrealized 0.0%
PROTEOSTASIS THERAPEUTICS INC 2.9%
Value $9.39M Shares 602,315 Est. Cost $15.59 Unrealized
EXACT SCIENCES CORP 2.8%
Value $9.285M Shares 500,000 Est. Cost Unrealized
ACHAOGEN INC 2.5%
Value $8.046M Shares 1,679,707 Est. Cost $3.85 Unrealized
CYTK CYTOKINETICS INC 2.4%
Value $7.772M Shares 846,654 Est. Cost $9.00 Unrealized +16.0%
KINDRED BIOSCIENCES INC 2.2%
Value $7.149M Shares 1,432,765 Est. Cost $7.10 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 1.7%
Value $5.418M Shares 357,365 Est. Cost $12.54 Unrealized +4.9%
ONC BEIGENE LTD 1.5%
Value $5.037M Shares 163,470 Est. Cost $29.75 Unrealized
IRONWOOD PHARMACEUTICALS INC 1.4%
Value $4.47M Shares 281,500 Est. Cost Unrealized
ASND ASCENDIS PHARMA A S 1.4%
Value $4.406M Shares 219,200 Est. Cost $20.10 Unrealized
SPARK THERAPEUTICS INC 1.3%
Value $4.12M Shares 68,600 Est. Cost $60.06 Unrealized
ADVERUM BIOTECHNOLOGIES INC 1.2%
Value $3.889M Shares 946,263 Est. Cost $4.11 Unrealized
NABRIVA THERAPEUTICS AG 1.2%
Value $3.87M Shares 548,912 Est. Cost $9.50 Unrealized
NTLA INTELLIA THERAPEUTICS INC 1.0%
Value $3.419M Shares 200,858 Est. Cost $26.61 Unrealized -27.2%
CHIMERIX INC 1.0%
Value $3.313M Shares 598,062 Est. Cost $5.54 Unrealized
ONCOMED PHARMACEUTICALS INC 0.9%
Value $3.038M Shares 265,784 Est. Cost $11.43 Unrealized
FATE FATE THERAPEUTICS INC 0.6%
Value $1.842M Shares 590,527 Est. Cost $2.43 Unrealized 0.0%
CHEMOCENTRYX INC 0.3%
Value $1.075M Shares 178,000 Est. Cost $6.04 Unrealized
SYROS PHARMACEUTICALS INC 0.3%
Value $882K Shares 63,596 Est. Cost $13.87 Unrealized
CASCADIAN THERAPEUTICS INC 0.1%
Value $170K Shares 103,800 Est. Cost Unrealized